Bringing your inventions to market: How your tech transfer office can help

Aronora: Blocked red blood cells

Technology transfer offices across the nation are celebrating the anniversary of the Bayh-Dole Act and how it has transformed the way universities, non-profit organizations and small businesses commercialize their inventions. OHSU’s Technology Transfer and Business Development celebrated another successful fiscal year in advancing technologies and bringing new inventions to market. These successes include:

  • The formation of six new startup companies based on OHSU technologies
  • A 35% increase in licensing revenue compared to the previous year
  • A 30% increase in new option and license agreements executed, compared to the previous year
  • Over twenty new U.S. patents issued on OHSU technologies
  • Over five hundred Material Transfer Agreements executed — second-highest total
  • Over three hundred Service Agreements executed — an all-time high
  • Nearly $20M awarded by industry for non-clinical research

Technology transfer offices are found in most large academic institutions and have become instrumental in bringing university-led inventions to market. Not only can they assist in finding the right industry partner to bring the invention to market, but they can help protect the intellectual property, typically through a license or patent.

Aronora, Inc. is a unique example of an OHSU startup based on OHSU technologies that benefited from the assistance of Technology Transfer and Business Development. Chief Executive Officer Andras Gruber, M.D., worked with Technology Transfer and Business Development to protect and develop several therapeutic technologies. This includes the development of ProCase, the first clot-busting drug to be approved by the FDA since 1987, currently in a phase 1 clinical safety trial. Aronora recently received Fast Track designation from the U.S. Food and Drug Administration for this new drug candidate as its unique capabilities reverses the formation of experimental blood clots without a significant increase in bleeding.

Collaborations such as this are instrumental in advancing research discoveries into applications in the health and commercial sectors for the benefit of society.

If you have an idea or invention, contact Technology Transfer and Business Development today.